Thought the call was fine. At least was professional and could understand them. There wasn't much new info, which is a bummer, but they said still moving along on most things we care about. It seemed rehearsed or reading from planned statements. I didn't hear any new bad news. Brazil trials restarting few weeks after safety review. Working on partnerships to pursue most indications. Several things going on research related, with interest in future partnerships if research plays out. NDAs in place. Looking for CEO and excited about candidates.